|
|
Blood, 9 April 2009, Vol. 113, No. 15, pp. 3612-3619.
Prepublished online as a Blood First Edition Paper on February 10, 2009; DOI 10.1182/blood-2008-07-168419.
Previous Article | Table of Contents | Next Article 
TRANSPLANTATION
Paradoxical effects of IFN- in graft-versus-host disease reflect promotion of lymphohematopoietic graft-versus-host reactions and inhibition of epithelial tissue injury
Hui Wang1,
Wannee Asavaroengchai1,
Beow Yong Yeap2,
Min-Guang Wang3,
Shumei Wang1,
Megan Sykes1, and
Yong-Guang Yang1
1 Bone Marrow Transplantation Section, Transplantation Biology Research Center, and
2 Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston; and
3 Lower Columbia Pathologists, Longview, WA
Interferon- (IFN- ) inhibits graft-versus-host disease (GVHD) in lethally irradiated mice receiving allogeneic hematopoietic cell transplantation (allo-HCT) but promotes lethality in unirradiated and sublethally irradiated recipients. We investigated the role of IFN- in GVHD in sublethally irradiated B6D2F1 recipients of B6 allo-HCT. B6D2F1 mice receiving wild-type B6 splenocytes alone died rapidly, whereas those receiving wild-type B6 splenocytes plus marrow survived long-term. Mice in both groups showed rapid elimination of host hematopoietic cells but minimal parenchymal tissue injury. However, mice receiving allo-HCT from IFN- –deficient donors died rapidly regardless of whether donor marrow was given, and they exhibited severe parenchymal injury but prolonged survival of host hematopoietic cells. IFN- plays a similar role in another model involving delayed B6 donor leukocyte infusion (DLI) to established mixed allogeneic (B6 BALB/c) chimeras. IFN- promotes DLI-mediated conversion from mixed to full donor chimerism while attenuating GVHD. Importantly, IFN- enhances graft-versus-leukemia (GVL) effects in both models. Our data indicate that previously reported IFN- –induced early mortality in allo-HCT recipients is due to augmentation of lymphohematopoietic graft-versus-host reaction (LGVHR) and can be avoided by providing an adequate source of donor hematopoietic stem/progenitor cells. Furthermore, the magnitude of GVL is correlated with the strength of LGVHR, and IFN- reduces the potential of this alloreactivity to cause epithelial tissue GVHD.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
|
|